SteelPeak Wealth’s Medline Inc MDLN Stock Holding History

SteelPeak Wealth’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,500	Closed	-$441K	–	664
2025 Q4	$441K	Buy	+10,500	New	+$443K	0.01%	372

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

SteelPeak Wealth's MDLN Position: Q1 2026 in Review

SteelPeak Wealth sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 10,500 shares — an estimated $441K sold.

SteelPeak Wealth first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $441K in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

SteelPeak Wealth reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
SteelPeak Wealth sold 10,500 Medline Inc shares in Q1 2026, an estimated $441K.
SteelPeak Wealth first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
SteelPeak Wealth's Medline Inc position peaked at $441K in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on SteelPeak Wealth's 13F filing for Q1 2026, filed 5 May 2026.